Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal womenJAHANZEB, Mohammad.Clinical therapeutics. 2007, Vol 29, Num 8, pp 1535-1547, issn 0149-2918, 13 p.Article

Southwest Oncology Group S0802: A Randomized, Phase II Trial of Weekly Topotecan With and Without Ziv-Aflibercept in Patients With Platinum-Treated Small-Cell Lung CancerALLEN, Jeffrey W; MOON, James; REDMAN, Mary et al.Journal of clinical oncology. 2014, Vol 32, Num 23, pp 2463-2470, issn 0732-183X, 8 p.Article

A process for measuring the Quality of cancer care: The Quality Oncology Practice InitiativeNEUSS, Michael N; DESCH, Christopher E; SIMONE, Joseph V et al.Journal of clinical oncology. 2005, Vol 23, Num 25, pp 6233-6239, issn 0732-183X, 7 p.Article

American Society of Clinical Oncology Guideline : Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With CancerLYMAN, Gary H; KHORANA, Alok A; MENDELSON, David et al.Journal of clinical oncology. 2007, Vol 25, Num 34, pp 5490-5505, issn 0732-183X, 16 p.Article

Docetaxel and carboplatin as first-line therapy in advanced non-small cell lung carcinoma: A phase II studyJAHANZEB, Mohammad; SARNA, Greg; MOTL, Susannah et al.Anticancer research. 2004, Vol 24, Num 2C, pp 1239-1242, issn 0250-7005, 4 p.Article

Efficacy and safety of liposomal anthracyclines in phase I/II clinical trialsALBERTS, David S; MUGGIA, Franco M; STEWART, Simon J et al.Seminars in oncology. 2004, Vol 31, Num 6, pp 53-90, issn 0093-7754, 38 p., SUP13Article